Literature DB >> 10946871

The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.

D A Fisher1, E J Schoen, S La Franchi, S H Mandel, J C Nelson, E I Carlton, J H Goshi.   

Abstract

Measurements of serum concentrations of free T4, T3, TSH, and thyroglobulin (Tg) were conducted in 42 infants (2-9 months of age) detected and treated through the Northwest Newborn Regional Screening Program and 63 children and adolescents (1-18 yr of age) with congenital hypothyroidism (CH) detected and managed in the Northern California Kaiser Permanente Medical Care Program. Normal feedback control axis data were developed by Quest Diagnostics, Inc. - Nichols Institute Diagnostics and Loma Linda University, from free T4 and TSH measurements in 589 healthy subjects, 2 months to 54 yr of age; 83 untreated hypothyroid patients; and 116 untreated hyperthyroid patients. Twenty-four of the 42 CH infants and 57 of the 63 CH children manifested serum TSH concentrations appropriate for the measured free T4 level. In the remaining 18 infants and 6 children, serum free T4 values were increased 0.2-1.4 ng/dL (2.6-18.0 pmol/L) for the prevailing TSH level, suggesting a state of mild to moderate pituitary-thyroid hormone resistance. In the treated children, the mean T3 concentration was lower (by 32%, 102 vs. 150 ng/dL; 1.57 vs. 2.31 nmol/L) than in normal children, in agreement with earlier data in hypothyroid adults treated with exogenous T4. Serum Tg concentrations were normal or elevated in 90% of the 19 children with ectopic glands and 93% of 27 children with eutopic glands in whom measurements were available. There was a positive correlation between serum TSH and Tg concentrations (P < 0.001), suggesting significant endogenous thyroid hormone production in these children. Our results suggest that the majority of infants and children with CH have a normal hypothalamic-pituitary-thyroid negative feedback control axis during treatment and that the measurement of serum TSH is a useful marker complementing the free T4 measurement in the management of children with CH. A minority have variable pituitary-thyroid hormone resistance, with relatively elevated serum TSH levels for their prevailing serum free T4 concentration. The prevalence of resistance is greater (43%) in young infants (< 1 yr of age) than in older children (10%), indicating that, in most children, the resistance improves with age.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10946871     DOI: 10.1210/jcem.85.8.6718

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Optimisation of thyroxine dose in congenital hypothyroidism.

Authors:  P C Hindmarsh
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

2.  A rare case of dyshormonogenetic fetal goiter responding to intra-amniotic thyroxine injections.

Authors:  Selwan Khamisi; Peter Lindgren; F Anders Karlsson
Journal:  Eur Thyroid J       Date:  2014-02-04

Review 3.  Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism.

Authors:  Andrew J Bauer; Ari J Wassner
Journal:  Endocrine       Date:  2019-07-26       Impact factor: 3.633

4.  Liothyronine Improves Biochemical Control of Congenital Hypothyroidism in Patients with Central Resistance to Thyroid Hormone.

Authors:  Laura Paone; Abby F Fleisch; Henry A Feldman; Rosalind S Brown; Ari J Wassner
Journal:  J Pediatr       Date:  2016-05-11       Impact factor: 4.406

5.  Similar age-dependent levothyroxine requirements of schoolchildren with congenital or acquired hypothyroidism.

Authors:  Martin Perlsteyn; Johnny Deladoëy; Guy Van Vliet
Journal:  Eur J Pediatr       Date:  2016-02-09       Impact factor: 3.183

6.  Low Thyroid Hormone Levels Disrupt Thyrotrope Development.

Authors:  Ksenia N Tonyushkina; Stefanie Krug; Theresa Ortiz-Toro; Tibor Mascari; Rolf O Karlstrom
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

7.  Excess Maternal Thyroxine Alters the Proliferative Activity and Angiogenic Profile of Growth Cartilage of Rats at Birth and Weaning.

Authors:  Lorena Gabriela Rocha Ribeiro; Juneo Freitas Silva; Natália de Melo Ocarino; Cíntia Almeida de Souza; Eliane Gonçalves de Melo; Rogéria Serakides
Journal:  Cartilage       Date:  2016-12-28       Impact factor: 4.634

Review 8.  Congenital hypothyroidism.

Authors:  Maynika V Rastogi; Stephen H LaFranchi
Journal:  Orphanet J Rare Dis       Date:  2010-06-10       Impact factor: 4.123

Review 9.  The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance.

Authors:  A Cassio; C Corbetta; I Antonozzi; F Calaciura; U Caruso; G Cesaretti; R Gastaldi; E Medda; F Mosca; E Pasquini; M C Salerno; V Stoppioni; M Tonacchera; G Weber; A Olivieri
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

10.  Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism.

Authors:  Jeremi M Carswell; Joshua H Gordon; Erica Popovsky; Andrea Hale; Rosalind S Brown
Journal:  J Clin Endocrinol Metab       Date:  2012-12-21       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.